{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:38Z","timestamp":1793275358595,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["P50-NS072187"],"award-info":[{"award-number":["P50-NS072187"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mangurian Foundation Lewy Body Dementia Program"},{"name":"CurePSP\/Tau Consortium Brain Bank"},{"name":"The Robert E. Jacoby Professorship"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.parkreldis.2017.07.033","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T05:32:28Z","timestamp":1501565548000},"page":"S30-S33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":561,"special_numbering":"S1","title":["Neuropathology of Parkinson disease"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2017.07.033_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib3","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1074\/jbc.R112.410530","article-title":"Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease","volume":"288","author":"Surmeier","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"issue":"Pt 8","key":"10.1016\/j.parkreldis.2017.07.033_bib4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00401-016-1542-4","article-title":"Proaggregant nuclear factor(s) trigger rapid formation of alpha-synuclein aggregates in apoptotic neurons","volume":"132","author":"Jiang","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00401-016-1660-z","article-title":"Histones facilitate alpha-synuclein aggregation during neuronal apoptosis","volume":"133","author":"Jiang","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-7-42","article-title":"Exosomal cell-to-cell transmission of alpha synuclein oligomers","volume":"7","author":"Danzer","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/mds.10488","article-title":"Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank","volume":"18","author":"Josephs","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib11","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/brain\/awm104","article-title":"Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome","volume":"130","author":"Williams","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib12","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","article-title":"Expanding the spectrum of neuronal pathology in multiple system atrophy","volume":"138","author":"Cykowski","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","article-title":"When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients","volume":"85","author":"Koga","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","article-title":"Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management","volume":"24","author":"Rabinovici","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2017.06.004","article-title":"DCTN1-related neurodegeneration: Perry syndrome and beyond","author":"Konno","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.parkreldis.2016.06.013","article-title":"Juvenile onset Parkinsonism with \u201cpure nigral\u201d degeneration and POLG1 mutation","volume":"30","author":"Mehta","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib19","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1212\/WNL.0000000000002744","article-title":"Absence of Lewy pathology associated with PINK1 homozygous mutation","volume":"86","author":"Takanashi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007400","article-title":"NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains","volume":"99","author":"Wakabayashi","year":"2000","journal-title":"Acta Neuropathol. Berl."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib22","first-page":"266","article-title":"Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations","volume":"2","author":"Fujishiro","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in\u00a0vivo and in\u00a0vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2017.07.033_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00019052-200108000-00001","article-title":"Alpha-synuclein and the Lewy body disorders","volume":"14","author":"Dickson","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jnen\/62.4.363","article-title":"Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease","volume":"62","author":"Parkkinen","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","article-title":"Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution\u2013a pilot study","volume":"106","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol. Berl."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib28","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1212\/01.wnl.0000204179.88955.fa","article-title":"Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals","volume":"66","author":"Klos","year":"2006","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2017.07.033_bib29","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.parkreldis.2004.10.014","article-title":"Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?","volume":"11","author":"Tsuboi","year":"2005","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.07.033_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:21Z","timestamp":1761178461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017302808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":30,"alternative-id":["S1353802017302808"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropathology of Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}